Atea Pharmaceuticals Inc (AVIR)
EBITDA Margin
18.84%
TTM · Period ending:
AVIR EBITDA Margin
Latest reported18.84%period ending
Latest reported18.84%period ending
AVIR TTM EBITDA Margin (-22.52% → 18.84%)
TTM ebitda margin
High-resolution chart · PNG
AVIR ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 18.8386% | |
| 11.516% | |
| 23.067% | |
| 39.4348% | |
| 18.273% | |
| 24.249% | |
| 20.6704% | |
| -22.5238% |